374 related articles for article (PubMed ID: 20007350)
1. Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
Whaley-Connell A; Nistala R; Habibi J; Hayden MR; Schneider RI; Johnson MS; Tilmon R; Rehmer N; Ferrario CM; Sowers JR
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F655-61. PubMed ID: 20007350
[TBL] [Abstract][Full Text] [Related]
2. Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat.
Whaley-Connell A; Habibi J; Cooper SA; Demarco VG; Hayden MR; Stump CS; Link D; Ferrario CM; Sowers JR
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E103-9. PubMed ID: 18460596
[TBL] [Abstract][Full Text] [Related]
3. Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat.
Whaley-Connell A; Habibi J; Nistala R; Hayden MR; Pulakat L; Sinak C; Locher B; Ferrario CM; Sowers JR
Regul Pept; 2012 Jun; 176(1-3):36-44. PubMed ID: 22465166
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.
Whaley-Connell A; Habibi J; Wei Y; Gutweiler A; Jellison J; Wiedmeyer CE; Ferrario CM; Sowers JR
Am J Physiol Renal Physiol; 2009 May; 296(5):F1013-22. PubMed ID: 19261739
[TBL] [Abstract][Full Text] [Related]
6. Renin inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling.
Whaley-Connell A; Habibi J; Rehmer N; Ardhanari S; Hayden MR; Pulakat L; Krueger C; Ferrario CM; DeMarco VG; Sowers JR
Metabolism; 2013 Jun; 62(6):861-72. PubMed ID: 23352204
[TBL] [Abstract][Full Text] [Related]
7. Despite similar reduction of blood pressure and renal ANG II and ET-1 levels aliskiren but not losartan normalizes albuminuria in hypertensive Ren-2 rats.
Vaňourková Z; Kramer HJ; Husková Z; Cervenka L; Vaněčková I
Physiol Res; 2010; 59(3):339-345. PubMed ID: 20666571
[TBL] [Abstract][Full Text] [Related]
8. Direct renin inhibition with aliskiren normalizes blood pressure in Cyp1a1-Ren2 transgenic rats with inducible angiotensin ii-dependent malignant hypertension.
Howard CG; Mullins JJ; Mitchell KD
Am J Med Sci; 2011 May; 341(5):383-7. PubMed ID: 21358304
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria.
Hayashi K; Sasamura H; Nakamura M; Sakamaki Y; Azegami T; Oguchi H; Tokuyama H; Wakino S; Hayashi K; Itoh H
Kidney Int; 2015 Oct; 88(4):745-53. PubMed ID: 26108068
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
Whaley-Connell A; Habibi J; Nistala R; Cooper SA; Karuparthi PR; Hayden MR; Rehmer N; DeMarco VG; Andresen BT; Wei Y; Ferrario C; Sowers JR
Hypertension; 2008 Feb; 51(2):474-80. PubMed ID: 18172055
[TBL] [Abstract][Full Text] [Related]
11. Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression.
Lastra G; Habibi J; Whaley-Connell AT; Manrique C; Hayden MR; Rehmer J; Patel K; Ferrario C; Sowers JR
Endocrinology; 2009 Jun; 150(6):2561-8. PubMed ID: 19246535
[TBL] [Abstract][Full Text] [Related]
12. Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat.
Habibi J; Whaley-Connell A; Hayden MR; DeMarco VG; Schneider R; Sowers SD; Karuparthi P; Ferrario CM; Sowers JR
Endocrinology; 2008 Nov; 149(11):5643-53. PubMed ID: 18653711
[TBL] [Abstract][Full Text] [Related]
13. Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.
Whaley-Connell A; Habibi J; Johnson M; Tilmon R; Rehmer N; Rehmer J; Wiedmeyer C; Ferrario CM; Sowers JR
Am J Nephrol; 2009; 30(4):354-60. PubMed ID: 19609077
[TBL] [Abstract][Full Text] [Related]
14. Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.
Sakoda M; Ichihara A; Kurauchi-Mito A; Narita T; Kinouchi K; Murohashi-Bokuda K; Saleem MA; Nishiyama A; Suzuki F; Itoh H
Am J Hypertens; 2010 May; 23(5):575-80. PubMed ID: 20075844
[TBL] [Abstract][Full Text] [Related]
15. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
[TBL] [Abstract][Full Text] [Related]
16. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.
Moniwa N; Varagic J; Ahmad S; VonCannon JL; Simington SW; Wang H; Groban L; Brosnihan KB; Nagata S; Kato J; Kitamura K; Gomez RA; Lopez ML; Ferrario CM
Hypertension; 2013 Feb; 61(2):417-24. PubMed ID: 23232645
[TBL] [Abstract][Full Text] [Related]
18. Chronic direct renin inhibition with aliskiren prevents the development of hypertension in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent hypertension.
Huang L; Howard CG; Mitchell KD
Am J Med Sci; 2012 Oct; 344(4):301-6. PubMed ID: 22261625
[TBL] [Abstract][Full Text] [Related]
19. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
